“Low-Dose Naltrexone”的搜索结果，显示 261-270 项，共有 5666 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... doses on a once daily schedule in participants with phenotypic classical FAP with disease involvement of the duodenum or the residual colon/rectum/pouch as ...

2. 血液科- 临床试验- 妙佑医疗国际

   Usual treatment after a complete response may include observation or high dose chemotherapy followed by an autologous stem cell transplant, however, it is not ...

3. 血液科- 临床试验- 妙佑医疗国际

   Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato, Minn., Eau Claire, Wis ...

4. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

6. 肺癌计划- 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

7. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

8. 血液科- 临床试验- 妙佑医疗国际

   Giving high dose chemotherapy followed by an autologous stem cell transplant may be more effective compared to observation only in treating patients with ...

9. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...